Back to Search Start Over

Treatment for patients with indolent and mantle cell lymphoma.

Authors :
Tsukasa Yamaguchi
Tomohiro Morita
Yukie Takahashi
Kenji Tsuda
Jinichi Mori
Source :
Lancet. 9/28/2013, Vol. 382 Issue 9898, p1094-1095. 2p.
Publication Year :
2013

Abstract

A letter to the editor is presented in response to the study by Mathias Rummel and colleagues on the use of bendamustine plus rituximab on patients with indolent lymphoma and mantle cell lymphoma in the April 6, 2013 issue.

Subjects

Subjects :
*RITUXIMAB
*LYMPHOMA treatment

Details

Language :
English
ISSN :
01406736
Volume :
382
Issue :
9898
Database :
Academic Search Index
Journal :
Lancet
Publication Type :
Academic Journal
Accession number :
90503447
Full Text :
https://doi.org/10.1016/S0140-6736(13)62018-8